Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology

Human Reproduction

Volumn 21, Issue 1, 2006, Pages 159-163

  Silberstein, T ^a   MacLaughlin, D T ^c   Shai, I ^d   Trimarchi, J R ^a   Lambert Messerlian, G ^b   Seifer, D B ^e   Keefe, D L ^a   Blazar, A S ^a  

^a BROWN UNIVERSITY   (United States)

^b Department of Pathology and Laboratory Medicine   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Embryo morphology; IVF; M llerian inhibiting substance; Ovarian reserve; Pregnancy rate

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN; GLYCOPROTEIN; MULLERIAN INHIBITING HORMONE; MULLERIAN-INHIBITING HORMONE; TESTIS PEPTIDE HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; EMBRYONAL TISSUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; MEASUREMENT; NIDATION; OOCYTE; OUTCOMES RESEARCH; OVARY FOLLICLE; PATIENT CARE; PREDICTION; PREGNANCY RATE; PROSPECTIVE STUDY; SCORING SYSTEM; CHEMISTRY; CYTOLOGY; OVARY; PROGNOSIS; TREATMENT OUTCOME;

CHORIONIC GONADOTROPIN; EMBRYO; FEMALE; FERTILIZATION IN VITRO; GLYCOPROTEINS; HUMANS; OVARY; PROGNOSIS; TESTICULAR HORMONES; TREATMENT OUTCOME;

EID: 29144452458     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei270     Document Type: Article

References (27)

1. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP and Grootegoed JA (1995) Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotrophin-induced follicle growth. Endocrinology 136,4951-4562.
2. Bancsi LF, Broekmans FJ, Eijkeman MJ, de Jong FJ, Habbema JDF and te Velde ER (2002) Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertil Steril 77,328-336.
3. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, and Chow EP (1986) Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45,685-698.
4. De Vet A, Laven JSE, de Jong FH, Themmen APN and Fauser BCJM (2002) Antimüllerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril 77,357-362.
5. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA and Themmen AP (2001) Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142,4891-4899.
6. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA and Themmen AP (2002) Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143,1076-1084.
7. Engmann L, Sladkevicius P, Agrawal R, Bekir JS, Campbell S and Tan SL (1999) Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Fertil Steril 71,22-29.
8. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R and Taieb J (2003a) Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 18,328-332.
9. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R and Taieb J (2003b) Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18,323-327.
10. Hanley JA, and McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143,29-36.
11. Hirobe S, He WW, Lee MM and Donahoe PK (1992) Müllerian inhibiting substance messenger ribonucleic acid expression in granulosa and sertoli cells coincides with their mitotic activity. Endocrinology 131,854-862.
12. Hudson PL, Douglas I, Donahoe PK, Cate RL, Epstein J, Pepinskey RB and MacLaughlin DT (1990) An immunoassay to detect human Müllerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 70,16-22.
13. Kupesic S, Kurjak A, Bjelos D and Vujisic S (2003) Predictors of IVF outcome by three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age. Fertil Steril 79,190-197.
14. Lass A, Skull J, McVeigh E, Margara R and Winston RM (1997) Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 12,294-297.
15. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D and MacLaughlin DT (1996) Müllerian inhibiting substance in human: Normal levels from infancy to adulthood. J Clin Endocrinol Metab 81,571-576.
16. McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham HA and Hsueh AJ (2001) Müllerian inhibitory substance induces growth of rat prenatal ovarian follicles. Biol Reprod 64,293-298.
17. Ng EHY, Yeung WSB, Fong DYT and Ho PC (2003) Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum Reprod 18,2169-2174.
18. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL and Skakkebaek NE (1999) Expression of anti-müllerian hormone during normal and pathological gonadal development: Association with differentiation of sertoli and granulosa cells. J Clin Endocrinol Metab 84,3836-3844.
19. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS and Berk CA (1997) Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 67,110-114.
20. Seifer DB, MacLaughlin DT, Christian BP, Feng B and Shelden RM (2002) Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77,468-471.
21. Syrop CH, Willhoite A and Van Voorhis BJ (1995) Ovarian volume: A novel outcome predictor for assisted reproduction. Fertil Steril 64,1167-1171.
22. Syrop CH, Dawson JD, Husman KJ, Sparks AE and Van Voorhis BJ (1999) Ovarian volume may predict assisted reproductive outcome better than follicle stimulating hormone concentration on day 3. Hum Reprod 14,1752-1756.
23. Tomas C, Noujua-Huttunen S and Martikainen H (1997) Pretreatment transvaginal ultrasound examination predicts ovarian responsivness to gonadotrophins in in-vitro fertilization. Hum Reprod 12,220-223.
24. Van Rooij IAJ, Broekmans FJ, de Jong FH, Themmen AP and Bancsi LF (2002a) Müllerian hormone levels as a novel measure of ovarian reserve. Hum Reprod 18,328-332.
25. Van Rooij IAJ, Broekmans FJM, te Velde ER, Fauser BCJM, Bancsi LF, de Jong FH and Themmen AP (2002b) Serum anti-Müllerian hormone levels: A novel measure of ovarian reserve. Hum Reprod 17,3065-3071.
26. Vigier B, Picard JY, Tran D, Legeai L and Josso N (1984) Production of anti-müllerian hormone: Another homology between sertoli and granulosa cells. Endocrinology 114,1315-1320.
27. Zaidi J, Barber J, Kyei-mensah A, Bekir J, Campbell S and Tan SL (1996) Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program. Obstet Gynecol 88,779-784.